Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities
Go back to Indivumed, Personalis Partner to Enhance Genomic Sequencing Capabilities| (NASDAQ: PSNL) | Delayed: 16.28 -0.05 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.33 | 52 Week High | $ | |||
| Open | $16.46 | 52 Week Low | $ | |||
| Day High | $16.58 | P/E | N/A | |||
| Day Low | $16.24 | EPS | $ | |||
| Volume | 172,531 | |||||

